The National Health Service was founded on a simple principle: healthcare should be available to everyone, regardless of wealth or background. Yet increasing amounts of NHS funding are being diverted into the hands of private healthcare companies, raising serious questions about whether public money is being used in the best interests of patients and taxpayers.
A recent study by the Centre for Health and Public Interest examined NHS spending on private healthcare providers in England over a two-year period. The findings were striking. The NHS spent approximately £12 billion on services provided by 760 private companies. Of that total, around £1.6 billion was lost as profit to private firms, while a further £2 billion was paid to companies registered outside the UK.
These figures represent money that could have been invested directly into frontline NHS services. According to the study, £1.6 billion could have funded the salaries of around 19,428 nurses or 9,178 doctors. At a time when NHS staff face overwhelming workloads, workforce shortages and increasing demand, such sums could have made a significant difference to patient care.
The impact is also felt locally. In North West London, which includes Ealing, the NHS spent £180.7 million on private companies. This substantial portion of the local healthcare budget could instead have funded approximately 258 nurses or 122 doctors, helping to address staffing pressures and improve services for residents.
Supporters of private healthcare often argue that private hospitals reduce pressure on the NHS by treating patients more quickly. However, the reality is far more complex. Private hospitals typically focus on straightforward, low-risk procedures that are less expensive and more profitable. More complicated and higher-risk cases remain the responsibility of NHS hospitals and staff.
This creates an uneven system in which private providers benefit from easier work while the NHS is left to handle the most challenging and resource-intensive treatments. In addition, many private healthcare companies rely on doctors, nurses and other clinical staff who were trained at public expense by the NHS. Taxpayers fund their education and training, only to see private companies profit from their expertise.
Every time NHS patients are referred to private providers, additional costs are incurred. Rather than strengthening public healthcare capacity, this approach risks diverting resources away from NHS services and into corporate profits. Many of the companies involved are large businesses with significant lobbying power and close connections to political decision-makers.
There is a different path. Investment in NHS infrastructure and services can increase capacity while keeping public money within the public healthcare system. Local projects such as new diagnostic centres and hospital extensions demonstrate how targeted investment can improve access to care, reduce waiting times and strengthen the NHS for the future.
The NHS belongs to all of us. Whether rich or poor, young or old, every person is likely to rely on it at some point in their life. At a time of continuing financial pressure and staff shortages, public funds should be focused on supporting NHS services, retaining skilled healthcare workers and improving patient care—not leaking away as private profit.
The debate about the future of healthcare is not simply about economics. It is about protecting a public service that remains one of the country’s most valued institutions. If we want a strong, sustainable NHS for future generations, investment must be directed towards strengthening public healthcare rather than subsidising private profit.
